The Association of Clinical Research Professionals

CAREER CENTER

Job Seekers, Welcome to ACRP Career Center
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 1403 Jobs
Save Agent
Loading... Please wait.
Kelly Science & Clinical Logo
Kelly Science & Clinical

Titusville, New Jersey

NEW! NEW!
Kelly Science & Clinical Logo
Kelly Science & Clinical

Philadelphia, Pennsylvania

University of Arizona College of Medicine-Phoenix Logo
University of Arizona College of Medicine-Phoenix

Phoenix, Arizona

Kaiser Permanente

Aurora, Colorado

Kaiser Permanente

Aurora, Colorado

Kelly Science & Clinical Logo
Kelly Science & Clinical

Santa Ana, California

Kelly Science & Clinical Logo
Kelly Science & Clinical

West Chester, Pennsylvania

Kelly Science & Clinical Logo
Kelly Science & Clinical

Irvine, California

DLH Logo
DLH

Silver Spring, Maryland

New Jersey Department of Children and Families

Trenton, New Jersey

New York Blood Logo
New York Blood

Long Island City, New York

Luminis Health Logo
Luminis Health

Annapolis, Maryland

Sutter Health

Walnut Creek, California

Sutter Health

Walnut Creek, California

Kelly Science & Clinical Logo
Kelly Science & Clinical

New York, New York

Kelly Science & Clinical Logo
Kelly Science & Clinical

Irvine, California

Kelly Science & Clinical Logo
Kelly Science & Clinical

San Diego, California

Sutter Health

Walnut Creek, California

Kelly Science & Clinical Logo
Kelly Science & Clinical

New York, New York

Loading... Please wait.
Manager or Senior Manager, Trial Operations
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, USA – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders.  At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the c


This job listing is no longer active.

Check the left side of the screen for similar opportunities.
Loading. Please wait.
Powered By Naylor Association Solutions